On August 25th, Winplus Technology released its semi-annual report for 2023. The company's operating income reached 4.801 billion yuan, representing a year-on-year growth of 3.84%. The net profit attributable to shareholders of the listed company amounted to 298 million yuan, reflecting an increase of 12.81% compared to the same period last year. The net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, stood at 263 million yuan, indicating a growth of 0.54% year-on-year. The basic earnings per share were 0.46 yuan. As for the e-cigarette business, the revenue amounted to 1.433 billion yuan, showing an astonishing year-on-year surge of 1477.33%. The operating profit and net profit amounted to 485 million yuan and 417 million yuan, respectively.
According to the report, Shenzhen Stocker Technology Co., Ltd., a subsidiary of the company, is engaged in the e-cigarette business. The company's e-cigarette business mainly focuses on brand operations, providing customers with e-cigarettes, pods, atomizers, and other e-cigarette accessories. Under the guidance of new regulations in the domestic e-cigarette industry, Stocker has obtained the Tobacco Monopoly Administration's issued "Tobacco Monopoly Production Enterprise License" and will vigorously develop its own brand business starting from 2022, actively expanding into overseas markets.
According to the report, in order to seize further opportunities in the European market and respond swiftly to customer service demands, the company's board of directors has approved the establishment of a wholly-owned subsidiary in the United Kingdom. This move aims to gradually achieve the goal of being based in the UK while extending its reach to Europe, allowing for a prompt response to e-cigarette business customers' pre-sales and after-sales service needs.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
